Concerned About Early Memory Changes?

Join a Clinical Research Study Evaluating an Investigational Treatment for Early Alzheimer’s Disease

When memory changes begin affecting everyday life, many families wonder what comes next.

Researchers are evaluating an investigational treatment for people with Early Alzheimer’s Disease to learn whether it may help slow disease progression..

If you or a loved one has been diagnosed with mild cognitive impairment (MCI) due to Alzheimer’s disease or early Alzheimer’s disease, you may qualify to participate.

See If You May Qualify

• Study-related care at no cost
• Access to an investigational treatment or placebo
• Comprehensive memory and cognitive assessments
• Ongoing monitoring by Alzheimer’s research specialists

Why Participate?

Alzheimer’s disease affects millions of individuals and families, yet many questions remain about how to slow its progression.

This clinical research study is evaluating an investigational treatment designed to target biological processes associated with Alzheimer’s disease.

By participating, you may help researchers better understand potential future treatment options while receiving ongoing evaluations throughout the study.

Who May Be Eligible?

You may qualify if you:

• Are between 50 and 85 years of age
• Have been diagnosed with mild cognitive impairment (MCI) due to Alzheimer’s disease or early Alzheimer’s disease
• Have a study partner (family member, spouse, caregiver, or close friend) who can attend certain study visits

Additional eligibility requirements apply.

What to Expect

Screening

The study team will review your medical history and perform assessments to determine eligibility.

Study Participation

Qualified participants will be randomly assigned to receive either:

• An investigational treatment, or
• Placebo

Neither participants nor study staff will know which treatment is assigned during the study.

Ongoing Evaluations

Study visits may include:

• Memory and thinking assessments
• Physical and neurological examinations
• Brain imaging scans
• Blood tests
• Safety monitoring

Continued Follow-Up

Researchers will continue monitoring participants over time to better understand how the investigational treatment may affect Alzheimer’s disease progression.

For Caregivers and Families

Caregivers play an important role in Alzheimer’s research.

A study partner helps researchers understand changes in day-to-day function, memory, and independence throughout the study.

Spouses, adult children, family members, close friends, and caregivers may be eligible to serve as study partners.

Take the Next Step

Help Advance Alzheimer’s Research

If you or a loved one is living with Early Alzheimer’s Disease, you may qualify for this clinical research study.

Check Eligibility Today

No obligation. Confidential. Takes only a few minutes.